PathAI: Transaction is part of wide-ranging collaboration to combine Quest's oncology expertise and scale with PathAI's AI and digital pathology innovations to speed diagnosis, improve quality and reduce costs  SECAUCUS, N.J. and BOSTON –...

More news from Philips this week - announcing a licensing agreement with Visiopharm to combine Visiopharm's breast cancer panel with Philips' Intellisite digital pathology solution. From a scientific standpoint, as the references mentioned...